FDA Drug recall D-0492-2017
Mirtazapine Tablets, USP 45 mg, a) 30 count, b) 100 count and c) 500 count bottles, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV
- FDA Drug
- Class II
- terminated
- Published 2017-03-15
On 2017-03-15 the FDA classified a Class II recall of Mirtazapine Tablets, USP 45 mg, a) 30 count, b) 100 count and c) 500 count bottles, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV by Mylan Pharmaceuticals, citing presence of Foreign Tablets/Capsules; possibility of Glipizide 10 mg tablet in bottle.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0492-2017 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2017-01-19 |
| Published | 2017-03-15 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Mylan Pharmaceuticals |
| Distribution | US |
Product
Mirtazapine Tablets, USP 45 mg, a) 30 count, b) 100 count and c) 500 count bottles, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV
Reason
Presence of Foreign Tablets/Capsules; possibility of Glipizide 10 mg tablet in bottle
Identifiers
| ndc | 0378-3515-70 |
|---|---|
| ndc | 0378-3515-93 |
| ndc | 0378-3515-01 |
| ndc | 0378-3515-10 |
| ndc | 0378-3530-70 |
| ndc | 0378-3530-93 |
| ndc | 0378-3530-01 |
| ndc | 0378-3530-05 |
| ndc | 0378-3545-70 |
| ndc | 0378-3545-93 |
| ndc | 0378-3545-01 |
| ndc | 0378-3545-05 |
| code_info | a) 3078937 and 3078938 (NDC 0378-3545-93), exp August 2019 b) 3078937 (NDC 0378-3545-01), exp August 2019 c) 3078936 (0378-3545-05), exp August 2019 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0492-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.